Showing results (351-360 of 432) with videos related to

Sort By:
Pageof 44
AIDS (London, England)|April 2, 2005
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosineAna Barrios, Ana Rendón, Eugenia Negredo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2011
Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitisMarylène Lejeune, José M Miró, Elisa De Lazzari, et al.
The New England Journal of Medicine|September 12, 2003
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infectionEsteban Martínez, Juan A Arnaiz, Daniel Podzamczer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2014
Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trialEsteban Martinez, Ana Gonzalez-Cordon, Elena Ferrer, et al.
AIDS Research and Human Retroviruses|August 17, 2006
Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in SpainM Angeles Rodríguez-Arenas, Inmaculada Jarrín, Julia del Amo, et al.
Frontiers in Immunology|October 3, 2022
Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomesVictòria Ceperuelo-Mallafré, Laia Reverté, Joaquim Peraire, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 4, 2014
[Consensus statement on monitoring of HIV: pregnancy, birth, and prevention of mother-to-child transmission], , , et al.
Pageof 44